Free Trial
NYSE:BIO.B

Bio-Rad Laboratories (BIO.B) Stock Price, News & Analysis

$326.78
0.00 (0.00%)
(As of 09/6/2024 ET)
Today's Range
$326.78
$326.78
50-Day Range
$268.88
$326.78
52-Week Range
$271.00
$373.78
Volume
1 shs
Average Volume
1,083 shs
Market Capitalization
$9.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BIO.B stock logo

About Bio-Rad Laboratories Stock (NYSE:BIO.B)

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

BIO.B Stock Price History

BIO.B Stock News Headlines

The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
The Analyst Landscape: 4 Takes On Bio-Rad Laboratories
The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
BIO Apr 2024 350.000 put
BIO Apr 2024 330.000 call
See More Headlines
Receive BIO.B Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/01/2024
Today
9/07/2024
Next Earnings (Estimated)
10/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NYSE:BIO.B
Employees
8,200
Year Founded
1952

Profitability

Net Income
$-637,320,000.00
Pretax Margin
-67.50%

Debt

Sales & Book Value

Annual Sales
$2.56 billion
Cash Flow
$12.11 per share
Book Value
$243.22 per share

Miscellaneous

Free Float
20,430,000
Market Cap
$9.32 billion
Optionable
Not Optionable
Beta
0.72

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Norman D. Schwartz (Age 72)
    Chairman, CEO & Pres
    Comp: $3.15M
  • Mr. Ilan Daskal (Age 56)
    Exec. VP & CFO
    Comp: $1.18M
  • Dr. Andrew J. Last Ph.D. (Age 62)
    Exec. VP & COO
    Comp: $1.54M
  • Mr. Michael Crowley (Age 60)
    Exec. VP of Global Commercial Operations
    Comp: $974.94k
  • Ms. Dara Grantham Wright (Age 46)
    Exec. VP & Pres of Clinical Diagnostics Group
    Comp: $1.06M
  • Mr. Ajit Ramalingam (Age 49)
    Sr. VP & Chief Accounting Officer
  • Mr. Yong Chung
    VP of Investor Relations
  • Mr. Timothy S. Ernst (Age 62)
    Exec. VP, Gen. Counsel & Sec.
  • Colleen Corey
    Sr. VP of Global HR
  • Lee Boyd
    Sr. VP of Global Commercial Operations - Asia Pacific

BIO.B Stock Analysis - Frequently Asked Questions

How have BIO.B shares performed this year?

Bio-Rad Laboratories' stock was trading at $320.65 on January 1st, 2024. Since then, BIO.B stock has increased by 1.9% and is now trading at $326.78.
View the best growth stocks for 2024 here
.

How were Bio-Rad Laboratories' earnings last quarter?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) released its quarterly earnings data on Thursday, August, 1st. The company reported $3.11 earnings per share for the quarter. The company earned $638.48 million during the quarter. Bio-Rad Laboratories had a negative net margin of 51.73% and a positive trailing twelve-month return on equity of 3.77%.

Does Bio-Rad Laboratories have any subsidiaries?

The following companies are subsidiaries of Bio-Rad Laboratories: Celsee, Raindance Technologies Limited, GnuBIO Inc., Bio-Rad AbD Serotec GmbH, QuantaLife, DiaMed Holding AG, Blackhawk Biosystems, and others.

How do I buy shares of Bio-Rad Laboratories?

Shares of BIO.B stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BIO.B) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners